Synchron Inc.

Executive Summary

Synchron Inc. is developing what it believes is the first minimally invasive implantable brain device that could help paralyzed patients: its neural interface, Stentrode, consists of an electrode array built onto a self-expanding stent that is implanted in a cerebral blood vessel. Once the stent is implanted, the array is designed to record local neuronal activity, then translate that activity into a signal that could be used to manipulate mobility-assist devices and return movement to the paralyzed user.